| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Methotrexate^1-2w post dose | LP307953-2 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Methotrexate | Serum or Plasma | Drug toxicology | LP390957-1 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| UNITSREQUIRED | Y |
| LONG_COMMON_NAME | en-US | Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose |
| LONG_COMMON_NAME | en-US | Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose |
| SHORTNAME | en-US | MTX 1-2W p SerPl-mCnc |
| ConsumerName | en-US | Methotrexate 1-2 weeks after dose, Blood |
| SHORTNAME | es-AR | METHOTREXATE:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo: |
| SHORTNAME | pt-BR | MTX 1-2W SerPl-mCnc |
| LONG_COMMON_NAME | fr-FR | Méthotrexate 1 à 2 semaines après administration [Masse/Volume] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | nl-NL | Methotrexaat^1-2 weken na dosis [massa/volume] in serum of plasma |
| LONG_COMMON_NAME | es-MX | Metotrexato : Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.77
FHIR